When Good Enough Won
The doctor didn't need distributed consensus algorithms. She needed the patient list to load.
MedSync Pro offered distributed consensus algorithms, HIPAA-compliant multi-region failover, real-time collaborative editing across clinical teams, and an audit trail system that could reconstruct any data state within the past seven years. The engineering team had spent four years building it. The sales cycle was nine months. The contract was $340,000 annually.
Dr. Reyes chose OpenClinic. It was free. It ran on a single server in a closet at her practice. It had no distributed consensus algorithms. It loaded the patient list in under two seconds, let her type notes, and printed referral letters. She evaluated MedSync Pro for forty-five minutes during a lunch break and asked one question: "Does it do what I need?" OpenClinic did. For zero dollars.
The MedSync Pro sales team lost the deal and documented it as "budget constraints." It wasn't budget constraints. It was the adequacy threshold — the point at which a cheaper solution crosses the minimum acceptable quality bar and every dollar spent above that line becomes waste.
The adequacy threshold has killed enterprise software before. Lotus Notes dominated enterprise communication until email became adequate. SharePoint dominated document management until Google Docs became adequate. Oracle dominated mid-market databases until PostgreSQL became adequate. In each case, the incumbent's technical superiority was real, measurable, and irrelevant.
The pattern follows a consistent sequence: an enterprise vendor builds capabilities that exceed customer requirements, a simpler alternative emerges that meets the actual requirements, and the market bifurcates into a small premium tier and a large commodity tier. The premium tier shrinks over time as the commodity alternative improves. It never shrinks fast. It just never stops shrinking.
Christensen documented this as the innovator's dilemma in 1997. The healthcare technology sector ignored it for two decades because regulatory complexity and data sensitivity created artificial barriers to entry. Those barriers are dissolving. Open-source HIPAA-compliant frameworks now exist. Cloud providers offer BAA-covered infrastructure by default. The moat was regulatory, and the drawbridge is down.
Enterprise healthcare software vendors report a 23% increase in deal losses to open-source or low-cost alternatives between 2023 and 2025. The losses are concentrated in the sub-500-bed hospital segment and independent practice market, where purchasing decisions are made by clinicians rather than IT committees.
The pattern is self-reinforcing. Each practice that adopts the free alternative contributes bug reports, feature requests, and occasionally code to the open-source project. OpenClinic's contributor base grew from 14 to 340 developers between 2021 and 2025. MedSync Pro's engineering team remained at 28. The development velocity gap is no longer closeable through hiring.
Dr. Reyes has not thought about MedSync Pro since that lunch break. Her patient list loads in under two seconds. She types notes. She prints referral letters. The distributed consensus algorithms that MedSync Pro spent four years building solve a problem she does not have and never will.
Terminal. The adequacy threshold for clinical practice management software has been crossed permanently. The remaining market for premium enterprise solutions is limited to large hospital networks and health systems where regulatory compliance, integration requirements, and organizational inertia sustain purchasing patterns that no longer reflect technical necessity.
MedSync Pro will not go bankrupt immediately. It will experience a slow compression of its addressable market as the open-source alternative absorbs the features that differentiate it. Each feature that migrates from premium to free shrinks the justification for the $340,000 contract. The sales team will be asked to "sell value" — the enterprise software industry's euphemism for justifying a price that the market no longer supports.
The velocity is stable because the terminal phase is not a collapse. It is a plateau. The outcome is already determined. The remaining question is duration, not direction. Eighteen to thirty-six months before the first major enterprise healthcare software vendor pivots to a services model. The product era for this segment is over.
- A prospect chose a free or low-cost alternative over your product despite inferior technical capabilities
- Your sales cycle has lengthened because buyers are evaluating open-source options they didn't know existed a year ago
- You've lost a deal to a solution that your engineering team considers technically inadequate
- A customer has described your product's advanced features as 'things we don't need'
- Your competitive analysis now includes tools built by one or two developers that replicate your core functionality
Read the full pattern analysis for a deeper understanding of the forces driving this assessment.
Read full pattern analysis →New assessments and pattern updates. Hear about it first.
This assessment covers one pattern in one profession. The book maps all of them. 30 years. Every pattern. Every archetype. Every exit.
The Complete Analysis →